Search Results - "Jochemsen, Hadassa M"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    APOE ε4 differentially influences change in memory performance depending on age. The SMART-MR study by Jochemsen, Hadassa M, Muller, Majon, van der Graaf, Yolanda, Geerlings, Mirjam I

    Published in Neurobiology of aging (01-04-2012)
    “…Abstract The apolipoprotein E (APOE) gene may act differently in young and old persons, known as antagonistic pleiotropy. We therefore examined the prospective…”
    Get full text
    Journal Article
  2. 2

    APOE epsilon 4 differentially influences change in memory performance depending on age. The SMART-MR study by Jochemsen, Hadassa M, Muller, Majon, van der Graaf, Yolanda, Geerlings, Mirjam I

    Published in Neurobiology of aging (01-04-2012)
    “…The apolipoprotein E (APOE) gene may act differently in young and old persons, known as antagonistic pleiotropy. We therefore examined the prospective…”
    Get full text
    Journal Article
  3. 3

    Blood pressure and progression of brain atrophy: the SMART-MR Study by Jochemsen, Hadassa M, Muller, Majon, Visseren, Frank L, Scheltens, Philip, Vincken, Koen L, Mali, Willem P, van der Graaf, Yolanda, Geerlings, Mirjam I

    Published in JAMA neurology (01-08-2013)
    “…Studies have shown that both high and low blood pressure (BP) may play a role in the etiology of brain atrophy. High BP in midlife has been associated with…”
    Get more information
    Journal Article
  4. 4

    Arterial stiffness and progression of structural brain changes: The SMART-MR study by Jochemsen, Hadassa M, Muller, Majon, Bots, Michiel L, Scheltens, Philip, Vincken, Koen L, Mali, Willem P T M, van der Graaf, Yolanda, Geerlings, Mirjam I

    Published in Neurology (03-02-2015)
    “…To examine the cross-sectional and prospective associations between arterial stiffness and structural brain changes within the Second Manifestations of…”
    Get full text
    Journal Article
  5. 5

    The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease by Jochemsen, Hadassa M, Teunissen, Charlotte E, Ashby, Emma L, van der Flier, Wiesje M, Jones, Ruth E, Geerlings, Mirjam I, Scheltens, Philip, Kehoe, Patrick G, Muller, Majon

    Published in Alzheimer's research & therapy (15-05-2014)
    “…Lower angiotensin-converting enzyme (ACE) activity could increase the risk of Alzheimer's disease (AD) as ACE functions to degrade amyloid-β (Aβ). Therefore,…”
    Get full text
    Journal Article
  6. 6

    Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy by Jochemsen, Hadassa M, van der Flier, Wiesje M, Ashby, Emma L, Teunissen, Charlotte E, Jones, Ruth E, Wattjes, Mike P, Scheltens, Philip, Geerlings, Mirjam I, Kehoe, Patrick G, Muller, Majon

    Published in Journal of Alzheimer's disease (01-01-2015)
    “…Higher angiotensin-converting enzyme (ACE) activity might increase the risk of Alzheimer's disease by increasing blood pressure, and subsequent development of…”
    Get more information
    Journal Article
  7. 7

    Serum angiotensin-converting enzyme and recurrent vascular events. The SMART-MR study by Jochemsen, Hadassa M, Geerlings, Mirjam I, Visseren, Frank L, Algra, Ale, van der Graaf, Yolanda, Muller, Majon

    Published in Atherosclerosis (01-10-2012)
    “…Abstract Objective Chronic exposure to high levels of angiotensin-converting enzyme (ACE) might increase the risk of hypertensive cardiovascular events…”
    Get full text
    Journal Article
  8. 8

    Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy--the SMART-MR study by Jochemsen, Hadassa M, Geerlings, Mirjam I, Grool, Anne M, Vincken, Koen L, Mali, Willem Ptm, van der Graaf, Yolanda, Muller, Majon

    Published in Journal of Alzheimer's disease (01-01-2012)
    “…High levels of angiotensin-converting-enzyme (ACE) may increase the risk of dementia through blood pressure elevation and subsequent development of cerebral…”
    Get more information
    Journal Article
  9. 9

    Homocysteine, progression of ventricular enlargement, and cognitive decline: The Second Manifestations of ARTerial disease-Magnetic Resonance study by Jochemsen, Hadassa M, Kloppenborg, Raoul P, de Groot, Lisette C.P.G.M, Kampman, Ellen, Mali, Willem P.T.M, van der Graaf, Yolanda, Geerlings, Mirjam I

    Published in Alzheimer's & dementia (01-05-2013)
    “…Abstract Background Homocysteine may be a modifiable risk factor for cognitive decline and brain atrophy, particularly in older persons. We examined whether…”
    Get full text
    Journal Article
  10. 10